United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.58%177.120.7%$1156.59m
LLYEli Lilly & Co. 0.96%372.061.1%$1068.92m
MRKMerck & Co., Inc. 1.06%110.080.7%$1002.54m
PFEPfizer Inc. 1.09%50.250.9%$935.84m
ABBVAbbVie, Inc. 0.98%165.321.9%$895.13m
BMYBristol-Myers Squibb Co. 0.01%79.931.1%$742.00m
AZNAstraZeneca Plc 0.42%68.851.0%$354.37m
HZNPHorizon Therapeutics Plc -0.57%96.305.4%$286.44m
GSKGSK Plc -2.74%36.880.3%$251.05m
IDXXIDEXX Laboratories, Inc. 1.13%420.103.9%$191.38m
NVSNovartis AG 1.09%91.730.2%$188.48m
CTLTCatalent, Inc. -2.05%47.231.9%$170.45m
ALNYAlnylam Pharmaceuticals, Inc. 5.32%231.338.0%$168.15m
NVONovo Nordisk A/S -0.42%125.260.1%$152.07m
SNYSanofi -1.26%47.940.2%$138.09m

Company Profile

United Therapeutics Corp. operates as a biotechnology company engaged in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It is involved in the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. The company was founded by Martine A. Rothblatt on June 26, 1996, and is headquartered in Silver Spring, MD.